Cytokinetics granted stock options covering 8,628 shares and 5,719 restricted stock units to five employees. The restricted stock units vest over three years, with 40% vesting after one year and 40% after two years. The remaining 20% of the restricted stock units vest after three years. The stock options have an exercise price of USD 60.06 per share and a 10-year term. The options vest over four years, with 25% vesting after one year and the remainder vesting monthly over the next 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603181600PRIMZONEFULLFEED9674545) on March 18, 2026, and is solely responsible for the information contained therein.